Jubilant Pharmova has reported results for first quarter ended June 30, 2021.
The company has reported net loss at Rs 1.13 crore for the quarter under review as compared to net profit at Rs 52.04 crore for the same quarter in the previous year. Total income of the company decreased by 96.81% at Rs 24.37 crore for Q1FY22 as compared Rs 762.93 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 82.43% in its net profit attributed to the owners at Rs 160.56 crore for the quarter under review as compared to net profit of 88.01 crore for the same quarter in the previous year. Total income of the company increased by 41.26% at Rs 1638.54 crore for Q1FY22 as compared Rs 1159.98 crore for the corresponding quarter previous year.
